CJC 1295 W DAC
5mg
CJC-1295 with DAC is a synthetic peptide that has attracted research interest for its prolonged activity on growth hormone signalling pathways. Supplied as a high-purity lyophilised peptide for laboratory research purposes only.
$97.00
Add to wishlist Add to compareAsk about productDescription
CJC-1295 with Drug Affinity Complex (DAC) is a synthetic analogue of growth hormone-releasing hormone (GHRH) designed to provide an extended duration of activity compared with native GHRH. The addition of the Drug Affinity Complex allows the peptide to bind to circulating albumin, increasing its half-life and making it a valuable tool for research into growth hormone regulation.
Researchers have investigated CJC-1295 with DAC for its effects on the physiological pathways responsible for pulsatile growth hormone release and insulin-like growth factor-1 (IGF-1) production. Its prolonged activity has made it a common subject of scientific studies examining endocrine function, body composition, recovery, metabolism, and healthy ageing.
Areas of Scientific Interest
- Research has investigated CJC-1295 with DAC for its ability to stimulate endogenous growth hormone release through activation of GHRH receptors.
- Clinical studies have reported sustained increases in circulating growth hormone and IGF-1 levels following administration, attributable to its extended half-life.
- Experimental research has explored its potential applications in studies involving body composition, muscle physiology, recovery, and metabolic regulation.
- Ongoing scientific investigations continue to examine the role of prolonged GHRH signalling in endocrine function and age-related physiological changes.
Product Features
- High-purity lyophilised peptide
- Contains 5mg CJC-1295 with Drug Affinity Complex (DAC)
- Manufactured for laboratory and scientific research
- Quality tested for identity and purity
- Securely packaged to help maintain product integrity
References
- Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting GHRH analog, in healthy adults. Journal of Clinical Endocrinology & Metabolism. 2006.
- Ionescu M, et al. Pharmacodynamics of CJC-1295, a long-acting GHRH analogue. Journal of Clinical Endocrinology & Metabolism. 2006.
- Veldhuis JD, et al. Growth hormone-releasing hormone analogues and regulation of the somatotropic axis. Endocrine Reviews.
Additional information
| Mg | 5mg, 10mg |
|---|
Reviews
There are no reviews yet.